Education
About Us
Working with TipRanks
Follow Us
Samantha Pearce Insider Profile
4 Followers
Samantha Pearce, EVP & CCO at Jazz Pharmaceuticals, holds 43.13K shares in Jazz Pharmaceuticals (Ticker: JAZZ).
Samantha Pearce Jazz Pharmaceuticals (JAZZ)EVP & CCO
Jazz Pharmaceuticals (JAZZ)
EVP & CCO
Ranked #40,121 out of 100,516 Corporate Insiders
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+18.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Samantha Pearce's holdings
Insider Roles
EVP & CCO
Roles that Samantha Pearce holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Jun 29, 2022 - Jun 29, 2023
Return:+20.90%
The most profitable trade made by Samantha Pearce
Samantha Pearce's Trading History
List of latest transactions for each holding click on a transaction to see Samantha Pearce's performance on stock
You May Also Like
Samantha Pearce insider profile FAQ
What is the percentage of profitable transactions made by Samantha Pearce?
The percentage of profitable transactions made by Samantha Pearce is 100%.
What is the average return per transaction made by Samantha Pearce?
The average return per transaction made by Samantha Pearce is 18.40%.
What stocks does Samantha Pearce hold?
Samantha Pearce holds: JAZZ stocks.
What was Samantha Pearce’s latest transaction?
Samantha Pearce latest transaction was an Uninformative Buy of ―.
What was Samantha Pearce's most profitable transaction?
Samantha Pearce’s most profitable transaction was an Informative Sell of JAZZ stock on June 29, 2022. The return on the trade was 20.90%.
What is Samantha Pearce's role in Jazz Pharmaceuticals?
Samantha Pearce's role in Jazz Pharmaceuticals is EVP & CCO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.